Socio-Clinical and Immuno-Inflammatory-Related Differences Between Early-Onset and Late onset Colorectal Cancer
1Nnamdi Azikiwe University
2Nnamdi Azikiwe University Teaching Hospital
3Aga Khan University Hospital Nairobi
Abstract
Introduction: This study aimed to identify socio-clinical and immuno-inflammatory markers of earlyonset colorectal cancer (CRC) for early detection of aggressive cancer in Southern Nigeria.
Material and Methods: This study included 89 patients with CRC diagnosed from Jan. 2016 to Dec. 2022. The patients were sub-grouped based on age and chemotherapy response. The neutrophil-tolymphocyte ratio (NLR), lymphocyte-to-monocyte ratio (LMR), platelet-to-lymphocyte ratio (PLR), platelets-neutrophils-to-lymphocytes ratio (PNLR), and neutrophils-to-lymphocytes platelets ratio (NLPR) were assessed and analyzed accordingly. Significance was set at p< 0.05.
Results: Metastatic and stage III/IV CRCs were prevalent among patients older than 50 years compared with patients aged 50 years or less (p< 0.05). Among patients aged > 50 years, the pre-treatment (pre-T) to post-treatment (post-T) total white blood cell count (TWBC), neutrophils, monocytes, and NLPR significantly increased whereas the post-T lymphocyte count and LMR significantly declined (p< 0.05). The Post-T TWBC count was significantly higher among patients aged > 50 years (14.20 ± 4.50 10^9 /L) compared with patients 50 years old or younger (9.19 ± 1.50 10^9 /L) whereas the Post-T monocyte count and LMR were lower among the former (9.12 ± 2.33 and 2.87 ± 0.60) than the post-T values of patients who were ≤50 years old (11.81 ± 3.57 and 6.76 ± 3.92) at p= 0.033, 0.026, and 0.001, respectively.
Conclusion: This study revealed a higher frequency of CRC and mortality risk among patients older than 50 years. It suggests that SIII could be used as a prognostic tool for CRC.
menu_book References
- Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: Cancer J Clin. 2021;71(3):209-49. Doi: 10.3322/caac.21660
- Arnold M, Sierra MS, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global patterns and trends in colorectal cancer incidence and mortality. Gut. 2017;66(4):683-91. doi:10.1136/gutjnl-2015-310912
- Alatise OI, Knapp GC, Bebington B, Ayodeji P, Dare A, Constable J, et al. Racial Differences in the Phenotype of Colorectal Cancer: A Prospective Comparison Between Nigeria and South Africa. World J Surg. 2022;46:47-53. Doi: 10.1007/s00268-021-06304-z
- Irabor DO, Afuwape OO, Ayandipo OO. The present status of the management of colon and rectal cancer in Nigeria. J Cancer Res. 2014. Doi: 10.1155/2014/267190.
- Alatise OI, Kingham TP. African Research Group for Oncology and MSKCC Global Cancer Disparity Initiative team. Abstract LB-327: Colorectal cancer in Nigeria: High tech and low-tech approaches to improving patient outcomes. Cancer Res. 2019;79(13_Supplement):LB-327. Doi:10.1158/1538-7445.AM2019-LB-327
- Irabor DO, Oluwasola OA, Ogunbiyi OJ, Ogun OG, Okolo CA, Melas M, et al. Microsatellite instability is common in colorectal cancer in native Nigerians. Anticancer Res. 2017;37(5):2649-54. Doi: 10.21873/anticanres.11612.
- Tejpar S, Stintzing S, Ciardiello F, Tabernero J, Van Cutsem E, Beier F, et al. Prognostic and predictive relevance of primary tumor location in patients with RAS wild-type metastatic colorectal cancer: retrospective analyses of the CRYSTAL and FIRE-3 trials. JAMA Oncol. 2017;3(2):194-201. doi:10.1001/jamaoncol.2016.3797
- Kim K, Castro EJ, Shim H, Advincula JVG, Kim YW. Differences regarding the molecular features and gut microbiota between right and left colon cancer. Ann Coloproctol. 2018;34(6):280. Doi: 10.3393%2Fac.2018.12.17
- Guo D, Li X, Xie A, Cao Q, Zhang J, Zhang F, et al. Differences in oncological outcomes and inflammatory biomarkers between right‐sided and left‐sided stage I‐III colorectal adenocarcinoma. J Clin Lab Anal. 2020;34(4):e23132. Doi: 10.1002/jcla.23132
- Pérez-Martelo M, González-García A, Vidal-Ínsua Y, Blanco-Freire C, Brozos-Vázquez EM, Abdulkader-Nallib I, et al. Clinical significance of baseline Pan-Immune-Inflammation Value and its dynamics in metastatic colorectal cancer patients under first-line chemotherapy. Sci Rep. 2022;12(1):6893. doi: 10.1038/s41598-022-10884-8
- Rossi S, Basso M, Strippoli A, Schinzari G, D'Argento E, Larocca M, et al. Are markers of systemic inflammation good prognostic indicators in colorectal cancer?. Clin Colorectal Cancer. 2017;16(4):264-74. doi: 10.1016/j.clcc.2017.03.015.
- Yamamoto T, Kawada K, Obama K. Inflammation-related biomarkers for the prediction of prognosis in colorectal cancer patients. Int J Mol Sci. 2021;22(15):8002. Doi: 10.3390/ijms22158002
- Watanabe H, Okada M, Kaji Y, Satouchi M, Sato Y, Yamabe Y, et al. New response evaluation criteria in solid tumours-revised RECIST guideline (version 1.1). Gan to kagaku ryoho. Cancer Chemother. 2009;36(13):2495-501.
- Saluja S, Alatise OI, Adewale A, Misholy J, Chou J, Gonen M, et al. A comparison of colorectal cancer in Nigerian and North American patients: is the cancer biology different? Surg. 2014;156(2):305-10. Doi: 10.1016/j.surg.2014.03.036
- Edino ST, Mohammed AZ, Chicha O. Characteristics of colorectal carcinoma in Kano. Nigeria: An analysis of 50 cases. Nig J Med. 2005;14(2):161-6.
- Holowatyj AN, Maude AS, Musa HS, Adamu A, Ibrahim S, Abdullahi, A et al. Patterns of early-onset colorectal cancer among Nigerians and African Americans. JCO Global Oncol. 2020;6:1647-55. Doi:10.1200%2FGO.20.00272
- Theyra-Enias H, Tumba N, Popoola OB. Management and outcome of colorectal cancer in a resource-limited setting: Ahmadu Bello University Teaching Hospital, Zaria, Nigeria. Nig J Clin Prac. 2022;25(6):923-30. Doi:10.4103/njcp.njcp_1948_21
- Irabor DO. Diet, environmental factors and increasing incidence of colorectal cancer in Nigeria. Ann Nig Med. 2014;8(2):58-64. DOI: 10.4103/0331-3131.153353
- Marx O, Mankarious M, Yochum G. Molecular genetics of early-onset colorectal cancer. World J Biol Chem. 2023;14(2):13. doi: 10.4331/wjbc.v14.i2.13
- Sharma A, Alatise OI, Adisa AO, Arowolo, OA, Olasehinde O, Famurewa, OC, et al. Treatment of colorectal cancer in Sub‐Saharan Africa: Results from a prospective Nigerian hospital registry. J Surg Oncol. 2020;121(2):342-9. Doi: 10.1002/jso.25768
- Li Y, Jia H, Yu W, Xu Y, Li X, Li, Q, et al. Nomograms for predicting prognostic value of inflammatory biomarkers in colorectal cancer patients after radical resection. Int J cancer. 2016;139(1):220-31. Doi: 10.1002/ijc.30071
Published in Vol. 7 No. 2 (2024): African Journal of Tropical Medicine and Biomedical Research, December 2024.
format_quote How to Cite
Copyright (c) 2025 African Journal of Tropical Medicine and Biomedical Research
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.